β-Catenin activation synergizes with PTEN loss to cause bladder cancer formation - Oncogene
Clicks: 271
ID: 272977
2010
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Popular Article
30.0
/100
271 views
49 readers
AI Quality Assessment
Not analyzed
Readership in this journal
PopularRanked #31 of 239 articles by views in Oncogene
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 239 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Although deregulation of the Wnt signalling pathway has been implicated in urothelial cell carcinoma (UCC), the functional significance is unknown. To test its importance, we have targeted expression of an activated form of β-catenin to the urothelium of transgenic mice using Cre–Lox technology (UroIICRE+ β-cateninexon3/+). Expression of this activated form of β-catenin led to the formation of localized hyperproliferative lesions by 3 months, which did not progress to malignancy. These lesions were characterized by a marked increase of the phosphatase and tensin homologue (PTEN) tumour suppressor protein. This appears to be a direct consequence of activating Wnt signalling in the bladder as conditional deletion of the adenomatous polyposis coli (Apc) gene within the adult bladder led rapidly to coincident β-catenin and PTEN expression. This PTEN expression blocked proliferation. Next, we combined PTEN deficiency with β-catenin activation and found that this caused papillary UCC. These tumours had increased pAKT signalling and were dependent on mammalian target of rapamycin (mTOR). Importantly, in human UCC, there was a significant correlation between high levels of β-catenin and pAKT (and low levels of PTEN). Taken together these data show that deregulated Wnt signalling has a critical role in promoting UCC, and suggests that human UCC that have high levels of Wnt and PI3 kinase signalling may be responsive to mTOR inhibition.
| Reference Key |
i2010oncogeneβ-catenin
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Ahmad, I;Morton, J P;Singh, L B;Radulescu, S M;Ridgway, R A;Patel, S;Woodgett, J;Winton, D J;Taketo, M M;Wu, X-R;Leung, H Y;Sansom, O J;Ahmad, I;Morton, J P;Singh, L B;Radulescu, S M;Ridgway, R A;Patel, S;Woodgett, J;Winton, D J;Taketo, M M;Wu, X-R;Leung, H Y;Sansom, O J; |
| Journal | Oncogene |
| Year | 2010 |
| DOI |
doi:10.1038/onc.2010.399
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.